Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Volatile organic compounds in COPD: Is hexanal an inflammation biomarker?

Maria Angeles Munoz, Javier Jareño, Óscar Gómez, Sergio Utrilla, Francisco Villegas, Carlos Gutiérrez, Luis Callol
European Respiratory Journal 2016 48: PA4412; DOI: 10.1183/13993003.congress-2016.PA4412
Maria Angeles Munoz
1Respiratory Research, Instituto Mixto de Investigaciones Biosanitarias de la Defensa, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Javier Jareño
2Respiratory Department, Hospital Central de la Defensa “Gómez Ulla”, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Óscar Gómez
1Respiratory Research, Instituto Mixto de Investigaciones Biosanitarias de la Defensa, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sergio Utrilla
1Respiratory Research, Instituto Mixto de Investigaciones Biosanitarias de la Defensa, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francisco Villegas
2Respiratory Department, Hospital Central de la Defensa “Gómez Ulla”, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlos Gutiérrez
1Respiratory Research, Instituto Mixto de Investigaciones Biosanitarias de la Defensa, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luis Callol
3Medical Department, Universidad de Alcalá, Alcalá de Henares, MadridSpain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Introduction: Volatile organic compounds (VOC) within exhaled breath are produced as a consequence of oxidative stress procedure in cell membranes. This determining could be of interest in COPD biomarkers research.

Objective: Determine whether there are differences between VOCin exhaled breath of COPD patients and healthy controls.

Method: Case-control study. 157 volunteers divided into 2 groups: healthy controls and COPD patients. Informed consent accepted.

Samples were collected using Bio-VOC® devices and were transferred to universal desorption tubes. Compounds were analyzed by gas chromatography and mass spectrometry.

VOC analyzed: hexanal, heptanal, nonanal, nonanoic acid and propionic acid (end-product of lipid peroxidation).

Statistical analyses using SPSS version 20.

Results: 57 COPD patients. Average age: 73,6 (9,5) years; Smoking index 74,4 (39,2) pack-years.

Control group: 100 healthy volunteers (33 smokers, 39 never smokers and 28 former smokers). Average age: 49 (9) years; Smoking index 29 (20) pack-years.

Hexanal showed statistically significant difference comparing the COPD group and all healthy controls (p=0,023).

When comparing never smokers from control group to COPD group we found statistically significant differences in both hexanal (p=0,015) and nonanal (p=0,008).

When comparing former smokers to COPD group we found statistically significant differences in hexanal (p=0,013). However, there weren´t any differences when comparing healthy smokers to COPD group.

Conclusions: Hexanal showed differences between COPD group and healthy controls. The difference between them is greater when comparing COPD group and non-active smokers from control group.

  • Biomarkers
  • COPD - diagnosis
  • Breath test
  • Copyright ©the authors 2016
Previous
Back to top
Vol 48 Issue suppl 60 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Volatile organic compounds in COPD: Is hexanal an inflammation biomarker?
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Volatile organic compounds in COPD: Is hexanal an inflammation biomarker?
Maria Angeles Munoz, Javier Jareño, Óscar Gómez, Sergio Utrilla, Francisco Villegas, Carlos Gutiérrez, Luis Callol
European Respiratory Journal Sep 2016, 48 (suppl 60) PA4412; DOI: 10.1183/13993003.congress-2016.PA4412

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Volatile organic compounds in COPD: Is hexanal an inflammation biomarker?
Maria Angeles Munoz, Javier Jareño, Óscar Gómez, Sergio Utrilla, Francisco Villegas, Carlos Gutiérrez, Luis Callol
European Respiratory Journal Sep 2016, 48 (suppl 60) PA4412; DOI: 10.1183/13993003.congress-2016.PA4412
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Comparison of phase III slope analysis from MBW with hyperpolarised gas MRI in children with mild CF
  • A statistical model to estimate lung density (LD) utilizing oscillometry (OS), biometrics (BM), patient reported outcomes (PRO) and pulmonary function tests (PFT)
  • A trial of the measurement of dynamic lung compliance by the new method using photoplethysmography in patients with COPD and pulmonary fibrosis
Show more 9.1 Respiratory Function Technologists/Scientists

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society